VANGUARD GROUP INC - ACUMEN PHARMACEUTICALS INC ownership

ACUMEN PHARMACEUTICALS INC's ticker is ABOS and the CUSIP is 00509G209. A total of 62 filers reported holding ACUMEN PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of ACUMEN PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$7,704,691
+118.0%
1,856,552
+152.6%
0.00%
Q2 2023$3,534,638
+18.5%
734,852
+0.0%
0.00%
Q1 2023$2,983,032
-22.8%
734,737
+2.6%
0.00%
Q4 2022$3,865,520
-40.8%
715,837
+10.0%
0.00%
Q3 2022$6,530,000
+118.5%
651,046
+2.4%
0.00%
Q2 2022$2,988,000
-38.1%
635,779
-48.5%
0.00%
Q1 2022$4,828,000
+28.7%
1,234,771
+122.5%
0.00%
Q4 2021$3,752,000
-80.9%
554,973
-58.1%
0.00%
Q3 2021$19,688,0001,324,8980.00%
Other shareholders
ACUMEN PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Sands Capital Ventures, LLC 3,417,075$14,180,8614.20%
Knollwood Investment Advisory, LLC 1,628,510$6,758,3173.16%
Altium Capital Management LP 650,000$2,697,5001.41%
RA Capital Management 14,932,063$61,968,0611.22%
GREAT POINT PARTNERS LLC 1,074,101$4,457,5190.81%
Boxer Capital, LLC 2,206,983$9,158,9790.49%
Deep Track Capital, LP 2,513,044$10,429,1330.40%
Parkman Healthcare Partners LLC 499,814$2,074,2280.38%
Rock Springs Capital Management LP 2,812,579$11,672,2030.31%
Ghost Tree Capital, LLC 150,000$622,5000.20%
View complete list of ACUMEN PHARMACEUTICALS INC shareholders